The sheer ubiquity of Gioblastoma (GBM) cases would lead you to believe that there should
have been many opportunities for the discovery of treatments to successfully render it into …

Simple Summary Prognosis for glioblastoma patients remains poor despite the current
standard of care treatments. More recent investigations have focused on immunotherapy …

Comprising only 1-10% of the circulating T cell population, γδT cells play a pivotal role in
cancer immunotherapy due to their unique amalgamation of innate and adaptive immune …

Despite a substantial increase in funding, activity, and interest, the overall picture regarding
outcomes of γδ T cell immunotherapeutic trials for cancer remains ambiguous. We set out to …

In this report, select key studies presented at the American Society of Clinical Oncology
(ASCO) 2021 annual meeting are reviewed. Two major phase III randomized controlled …